StockData
PYRGFOTCPharmaceutical PreparationsFiscal year ends December 31

PyroGenesis Canada Inc.

Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 40-F on Mar 31, 2023
$0.16+0.00 (+2.73%)

Close on Oct 19, 2026

About PyroGenesis Canada

Pharmaceutical Preparations, SIC 2834

The reporting details indicate that the company operates in technical and industrial solutions, offering offerings that include Purevap, Drosrite, torch-related systems, and biogas upgrading and pollution controls. Its commercial activities include development and support services, intellectual property agreements, and equipment delivery, with revenue derived from goods and services provided both over time and at discrete points in time to enterprise customers.

Geographically, the reporting details identify operations or jurisdictions in Canada and India. The provided excerpt contains references to subsidiaries such as PyroGreenGas and investments in external entities, but it does not specify a corporate headquarters location, facility count, or broader international branch network.

Summary of the business section of PyroGenesis Canada's latest annual report, written by StockData.

Company profile

Company

Legal name
PyroGenesis Canada Inc.
Founded
2006
Headquarters
Montreal, A8
Address
1744 William Street, Suite 200 H3J 1R4
Phone
514-937-0002 EXT 227
Website
www.pyrogenesis.com
Industry
Pharmaceutical Preparations
Incorporated in
A8
Fiscal year ends
December 31
Auditor
Raymond Chabot Grant Thornton LLP, Montreal, Canada

Stock & identifiers

Ticker
PYRGF
Exchange
OTC
IPO date
Aug 15, 2011
Shares outstanding
174M, Dec 31, 2022
Filer category
<br>Emerging growth company
SEC CIK
1743344
CUSIP
74739V104
ISIN
US74739V1044
EIN
98-0627529

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

PyroGenesis Canada's leadership is listed in its proxy statement (Form DEF 14A).

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 6, 2023DelistingNotice of delisting from exchange (Form 25)